Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
29001
29002
29003
29004
29005
29006
29007
29008
29009
29010
29011
29012
29013
29014
29015
29016
29017
29018
29019
29020
29021
29022
29023
29024
29025
29026
29027
29028
29029
29030
29031
29032
29033
29034
29035
29036
29037
29038
29039
29040
29041
29042
29043
29044
29045
29046
29047
29048
29049
29050
29051
29052
29053
29054
29055
29056
29057
29058
29059
29060
29061
29062
29063
29064
29065
29066
29067
29068
29069
29070
29071
29072
29073
29074
29075
29076
29077
29078
29079
29080
29081
29082
29083
29084
29085
29086
29087
29088
29089
29090
29091
29092
29093
29094
29095
29096
29097
29098
29099
29100
29101
29102
29103
29104
29105
29106
29107
29108
29109
29110
29111
29112
29113
29114
29115
29116
29117
29118
29119
29120
29121
29122
29123
29124
29125
29126
29127
29128
29129
29130
29131
29132
29133
29134
29135
29136
29137
29138
29139
29140
29141
29142
29143
29144
29145
29146
29147
29148
29149
29150
29151
29152
29153
29154
29155
29156
29157
29158
29159
29160
29161
29162
29163
29164
29165
29166
29167
29168
29169
29170
29171
29172
29173
29174
29175
29176
29177
29178
29179
29180
29181
29182
29183
29184
29185
29186
29187
29188
29189
29190
29191
29192
29193
29194
29195
29196
29197
29198
29199
29200
| UnnamedSample_HQ_transcript/4658|m.2056 | UnnamedSample_HQ_transcript/4658 | Identity 0.731 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/4373|m.1945 | UnnamedSample_HQ_transcript/4373 | Identity 0.730 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/4373|m.1945 | UnnamedSample_HQ_transcript/4373 | Identity 0.730 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/80819|m.19841 | UnnamedSample_HQ_transcript/80819 | Coverage 0.553 too low. | d0ef2e3050637ef37bf9e112ab78a280 | 412 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 48 | 410 | 1.6E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/90753|m.21370 | UnnamedSample_HQ_transcript/90753 | Coverage 0.555 too low. | d0ef2e3050637ef37bf9e112ab78a280 | 412 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 48 | 410 | 1.6E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/71020|m.18114 | UnnamedSample_HQ_transcript/71020 | Coverage 0.468 too low. | d0ef2e3050637ef37bf9e112ab78a280 | 412 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 48 | 410 | 1.6E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/84803|m.20461 | UnnamedSample_HQ_transcript/84803 | Coverage 0.578 too low. | d0ef2e3050637ef37bf9e112ab78a280 | 412 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 48 | 410 | 1.6E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/63999|m.16840 | UnnamedSample_HQ_transcript/63999 | Coverage 0.678 too low. | d0ef2e3050637ef37bf9e112ab78a280 | 412 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 48 | 410 | 1.6E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/86049|m.20662 | UnnamedSample_HQ_transcript/86049 | Coverage 0.988 too low. | ffbb094d58a79fc80ebf3747a144719a | 416 | Pfam | PF09606 | ARC105 or Med15 subunit of Mediator complex non-fungal | 18 | 178 | 2.8E-26 | T | 22-09-2020 | IPR019087 | Mediator of RNA polymerase II transcription subunit 15 |
| UnnamedSample_HQ_transcript/86049|m.20662 | UnnamedSample_HQ_transcript/86049 | Coverage 0.988 too low. | ffbb094d58a79fc80ebf3747a144719a | 416 | Pfam | PF09606 | ARC105 or Med15 subunit of Mediator complex non-fungal | 281 | 414 | 1.1E-13 | T | 22-09-2020 | IPR019087 | Mediator of RNA polymerase II transcription subunit 15 |
| UnnamedSample_HQ_transcript/3324|m.1572 | UnnamedSample_HQ_transcript/3324 | Coverage 0.425 too low. | ba5643f6d369e8457fb8d86231826a03 | 1005 | Pfam | PF02210 | Laminin G domain | 649 | 791 | 1.4E-21 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3324|m.1572 | UnnamedSample_HQ_transcript/3324 | Coverage 0.425 too low. | ba5643f6d369e8457fb8d86231826a03 | 1005 | Pfam | PF01049 | Cadherin cytoplasmic region | 849 | 986 | 6.1E-45 | T | 22-09-2020 | IPR000233 | Cadherin, cytoplasmic domain |
| UnnamedSample_HQ_transcript/3324|m.1572 | UnnamedSample_HQ_transcript/3324 | Coverage 0.425 too low. | ba5643f6d369e8457fb8d86231826a03 | 1005 | Pfam | PF00028 | Cadherin domain | 115 | 204 | 5.8E-9 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/3324|m.1572 | UnnamedSample_HQ_transcript/3324 | Coverage 0.425 too low. | ba5643f6d369e8457fb8d86231826a03 | 1005 | Pfam | PF00028 | Cadherin domain | 13 | 98 | 3.9E-16 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/3324|m.1572 | UnnamedSample_HQ_transcript/3324 | Coverage 0.425 too low. | ba5643f6d369e8457fb8d86231826a03 | 1005 | Pfam | PF00028 | Cadherin domain | 232 | 319 | 2.0E-10 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/78751|m.19510 | UnnamedSample_HQ_transcript/78751 | Coverage 0.970 too low. | 289f555f77248665da7940e2fa12a687 | 412 | Pfam | PF03022 | Major royal jelly protein | 124 | 408 | 1.2E-95 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/55258|m.15084 | UnnamedSample_HQ_transcript/55258 | Coverage 0.958 too low. | 289f555f77248665da7940e2fa12a687 | 412 | Pfam | PF03022 | Major royal jelly protein | 124 | 408 | 1.2E-95 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/60670|m.16193 | UnnamedSample_HQ_transcript/60670 | Coverage 0.946 too low. | 289f555f77248665da7940e2fa12a687 | 412 | Pfam | PF03022 | Major royal jelly protein | 124 | 408 | 1.2E-95 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/66282|m.17264 | UnnamedSample_HQ_transcript/66282 | Coverage 0.963 too low. | 289f555f77248665da7940e2fa12a687 | 412 | Pfam | PF03022 | Major royal jelly protein | 124 | 408 | 1.2E-95 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/76392|m.19096 | UnnamedSample_HQ_transcript/76392 | Coverage 0.514 too low. | baa3ef4f6198e079a0b82302d6ef1988 | 276 | Pfam | PF06775 | Putative adipose-regulatory protein (Seipin) | 3 | 200 | 1.2E-58 | T | 22-09-2020 | IPR009617 | Seipin family |
| UnnamedSample_HQ_transcript/6913|m.2832 | UnnamedSample_HQ_transcript/6913 | Coverage 0.868 too low. | 3c2052e161b604869e04de306b9627db | 389 | Pfam | PF12347 | Holliday junction regulator protein family C-terminal repeat | 101 | 159 | 3.0E-12 | T | 22-09-2020 | IPR022102 | Holliday junction regulator protein family C-terminal |
| UnnamedSample_HQ_transcript/6913|m.2832 | UnnamedSample_HQ_transcript/6913 | Coverage 0.868 too low. | 3c2052e161b604869e04de306b9627db | 389 | Pfam | PF00319 | SRF-type transcription factor (DNA-binding and dimerisation domain) | 10 | 57 | 2.6E-24 | T | 22-09-2020 | IPR002100 | Transcription factor, MADS-box |
| UnnamedSample_HQ_transcript/5929|m.2518 | UnnamedSample_HQ_transcript/5929 | Coverage 0.092 too low. | 3c2052e161b604869e04de306b9627db | 389 | Pfam | PF12347 | Holliday junction regulator protein family C-terminal repeat | 101 | 159 | 3.0E-12 | T | 22-09-2020 | IPR022102 | Holliday junction regulator protein family C-terminal |
| UnnamedSample_HQ_transcript/5929|m.2518 | UnnamedSample_HQ_transcript/5929 | Coverage 0.092 too low. | 3c2052e161b604869e04de306b9627db | 389 | Pfam | PF00319 | SRF-type transcription factor (DNA-binding and dimerisation domain) | 10 | 57 | 2.6E-24 | T | 22-09-2020 | IPR002100 | Transcription factor, MADS-box |
| UnnamedSample_HQ_transcript/6336|m.2649 | UnnamedSample_HQ_transcript/6336 | Coverage 0.790 too low. | 3c2052e161b604869e04de306b9627db | 389 | Pfam | PF12347 | Holliday junction regulator protein family C-terminal repeat | 101 | 159 | 3.0E-12 | T | 22-09-2020 | IPR022102 | Holliday junction regulator protein family C-terminal |
| UnnamedSample_HQ_transcript/6336|m.2649 | UnnamedSample_HQ_transcript/6336 | Coverage 0.790 too low. | 3c2052e161b604869e04de306b9627db | 389 | Pfam | PF00319 | SRF-type transcription factor (DNA-binding and dimerisation domain) | 10 | 57 | 2.6E-24 | T | 22-09-2020 | IPR002100 | Transcription factor, MADS-box |
| UnnamedSample_HQ_transcript/20237|m.6930 | UnnamedSample_HQ_transcript/20237 | Identity 0.808 too low. | 8d81ac031f5d1da64f5488eab6981fc7 | 574 | Pfam | PF01204 | Trehalase | 27 | 539 | 4.0E-150 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/43585|m.12614 | UnnamedSample_HQ_transcript/43585 | Unmapped. | f8d1c25b2ab821e43ff10007e0ebf9e1 | 438 | Pfam | PF00910 | RNA helicase | 55 | 163 | 8.7E-19 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/28131|m.9003 | UnnamedSample_HQ_transcript/28131 | Identity 0.678 too low. | f817de542f034f6bb04e31299c5e583b | 742 | Pfam | PF03571 | Peptidase family M49 | 173 | 718 | 4.1E-224 | T | 22-09-2020 | IPR039461 | Peptidase family M49 |
| UnnamedSample_HQ_transcript/34269|m.10537 | UnnamedSample_HQ_transcript/34269 | Identity 0.655 too low. | f817de542f034f6bb04e31299c5e583b | 742 | Pfam | PF03571 | Peptidase family M49 | 173 | 718 | 4.1E-224 | T | 22-09-2020 | IPR039461 | Peptidase family M49 |
| UnnamedSample_HQ_transcript/30993|m.9711 | UnnamedSample_HQ_transcript/30993 | Identity 0.665 too low. | f817de542f034f6bb04e31299c5e583b | 742 | Pfam | PF03571 | Peptidase family M49 | 173 | 718 | 4.1E-224 | T | 22-09-2020 | IPR039461 | Peptidase family M49 |
| UnnamedSample_HQ_transcript/28718|m.9146 | UnnamedSample_HQ_transcript/28718 | Identity 0.669 too low. | f817de542f034f6bb04e31299c5e583b | 742 | Pfam | PF03571 | Peptidase family M49 | 173 | 718 | 4.1E-224 | T | 22-09-2020 | IPR039461 | Peptidase family M49 |
| UnnamedSample_HQ_transcript/32955|m.10200 | UnnamedSample_HQ_transcript/32955 | Identity 0.664 too low. | f817de542f034f6bb04e31299c5e583b | 742 | Pfam | PF03571 | Peptidase family M49 | 173 | 718 | 4.1E-224 | T | 22-09-2020 | IPR039461 | Peptidase family M49 |
| UnnamedSample_HQ_transcript/66537|m.17322 | UnnamedSample_HQ_transcript/66537 | Identity 0.775 too low. | db0ced7c0c1175c4551cdd2e8db987b4 | 341 | Pfam | PF00096 | Zinc finger, C2H2 type | 222 | 244 | 3.6E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/66537|m.17322 | UnnamedSample_HQ_transcript/66537 | Identity 0.775 too low. | db0ced7c0c1175c4551cdd2e8db987b4 | 341 | Pfam | PF00096 | Zinc finger, C2H2 type | 194 | 214 | 0.0091 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/68092|m.17596 | UnnamedSample_HQ_transcript/68092 | Coverage 0.855 too low. | e020f460de4efae6246977edbbfb8174 | 238 | Pfam | PF01048 | Phosphorylase superfamily | 1 | 194 | 5.9E-22 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/8665|m.3402 | UnnamedSample_HQ_transcript/8665 | Coverage 0.909 too low. | 1f66ead0e7c584a24fded6c97b3896bb | 547 | Pfam | PF00595 | PDZ domain | 75 | 154 | 2.3E-6 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/12655|m.4712 | UnnamedSample_HQ_transcript/12655 | Coverage 0.149 too low. | c735d3bdc9ab92442014ab73f2adda2f | 623 | Pfam | PF00520 | Ion transport protein | 153 | 414 | 1.4E-20 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/12655|m.4712 | UnnamedSample_HQ_transcript/12655 | Coverage 0.149 too low. | c735d3bdc9ab92442014ab73f2adda2f | 623 | Pfam | PF08412 | Ion transport protein N-terminal | 108 | 151 | 1.5E-24 | T | 22-09-2020 | IPR013621 | Ion transport N-terminal |
| UnnamedSample_HQ_transcript/12655|m.4712 | UnnamedSample_HQ_transcript/12655 | Coverage 0.149 too low. | c735d3bdc9ab92442014ab73f2adda2f | 623 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 506 | 588 | 9.2E-19 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/35739|m.10868 | UnnamedSample_HQ_transcript/35739 | Coverage 0.218 too low. | c735d3bdc9ab92442014ab73f2adda2f | 623 | Pfam | PF00520 | Ion transport protein | 153 | 414 | 1.4E-20 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/35739|m.10868 | UnnamedSample_HQ_transcript/35739 | Coverage 0.218 too low. | c735d3bdc9ab92442014ab73f2adda2f | 623 | Pfam | PF08412 | Ion transport protein N-terminal | 108 | 151 | 1.5E-24 | T | 22-09-2020 | IPR013621 | Ion transport N-terminal |
| UnnamedSample_HQ_transcript/35739|m.10868 | UnnamedSample_HQ_transcript/35739 | Coverage 0.218 too low. | c735d3bdc9ab92442014ab73f2adda2f | 623 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 506 | 588 | 9.2E-19 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/41857|m.12230 | UnnamedSample_HQ_transcript/41857 | Coverage 0.366 too low. | ac94cabf8cded83676dbaf7a2c972f47 | 474 | Pfam | PF15997 | Domain of unknown function (DUF4772) | 5 | 120 | 1.6E-33 | T | 22-09-2020 | IPR031940 | Domain of unknown function DUF4772 |
| UnnamedSample_HQ_transcript/18970|m.6570 | UnnamedSample_HQ_transcript/18970 | Coverage 0.943 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 43 | 164 | 2.7E-25 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/18970|m.6570 | UnnamedSample_HQ_transcript/18970 | Coverage 0.943 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF06311 | NUMB domain | 256 | 368 | 7.6E-33 | T | 22-09-2020 | IPR010449 | NUMB domain |
| UnnamedSample_HQ_transcript/16468|m.5851 | UnnamedSample_HQ_transcript/16468 | Coverage 0.110 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 43 | 164 | 2.7E-25 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/16468|m.5851 | UnnamedSample_HQ_transcript/16468 | Coverage 0.110 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF06311 | NUMB domain | 256 | 368 | 7.6E-33 | T | 22-09-2020 | IPR010449 | NUMB domain |
| UnnamedSample_HQ_transcript/18709|m.6501 | UnnamedSample_HQ_transcript/18709 | Coverage 0.074 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 43 | 164 | 2.7E-25 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/18709|m.6501 | UnnamedSample_HQ_transcript/18709 | Coverage 0.074 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF06311 | NUMB domain | 256 | 368 | 7.6E-33 | T | 22-09-2020 | IPR010449 | NUMB domain |
| UnnamedSample_HQ_transcript/19312|m.6671 | UnnamedSample_HQ_transcript/19312 | Coverage 0.044 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 43 | 164 | 2.7E-25 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/19312|m.6671 | UnnamedSample_HQ_transcript/19312 | Coverage 0.044 too low. | 56e5d810a3b4ff4bffc7e51244c43481 | 646 | Pfam | PF06311 | NUMB domain | 256 | 368 | 7.6E-33 | T | 22-09-2020 | IPR010449 | NUMB domain |
| UnnamedSample_HQ_transcript/43323|m.12561 | UnnamedSample_HQ_transcript/43323 | Identity 0.847 too low. | 35a5b201d2fdfa00ac0eca172f4d6ce2 | 382 | Pfam | PF00017 | SH2 domain | 225 | 303 | 5.4E-10 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/43323|m.12561 | UnnamedSample_HQ_transcript/43323 | Identity 0.847 too low. | 35a5b201d2fdfa00ac0eca172f4d6ce2 | 382 | Pfam | PF02864 | STAT protein, DNA binding domain | 1 | 105 | 5.3E-30 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/694|m.486 | UnnamedSample_HQ_transcript/694 | Unmapped. | 8bc4b81f06451730e9931098a969112a | 1045 | Pfam | PF13087 | AAA domain | 135 | 306 | 7.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/12649|m.4711 | UnnamedSample_HQ_transcript/12649 | Coverage 0.193 too low. | 9d8ee777ae556b3d79fc806f9081d3c9 | 384 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 239 | 307 | 5.9E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/12649|m.4711 | UnnamedSample_HQ_transcript/12649 | Coverage 0.193 too low. | 9d8ee777ae556b3d79fc806f9081d3c9 | 384 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 151 | 219 | 5.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/38466|m.11500 | UnnamedSample_HQ_transcript/38466 | Coverage 0.311 too low. | ba797acf515ea21e75fedfd72c6354e0 | 269 | Pfam | PF12884 | Transducer of regulated CREB activity, N terminus | 5 | 47 | 1.3E-18 | T | 22-09-2020 | IPR024783 | Transducer of regulated CREB activity, N-terminal |
| UnnamedSample_HQ_transcript/38466|m.11500 | UnnamedSample_HQ_transcript/38466 | Coverage 0.311 too low. | ba797acf515ea21e75fedfd72c6354e0 | 269 | Pfam | PF12885 | Transducer of regulated CREB activity middle domain | 147 | 237 | 2.0E-15 | T | 22-09-2020 | IPR024784 | Transducer of regulated CREB activity, middle domain |
| UnnamedSample_HQ_transcript/2543|m.1247 | UnnamedSample_HQ_transcript/2543 | Coverage 0.301 too low. | a2675aca816a9da3291fde7455ae37b8 | 1360 | Pfam | PF16471 | JNK-interacting protein leucine zipper II | 374 | 444 | 2.6E-31 | T | 22-09-2020 | IPR032486 | JNK-interacting protein, leucine zipper II |
| UnnamedSample_HQ_transcript/2543|m.1247 | UnnamedSample_HQ_transcript/2543 | Coverage 0.301 too low. | a2675aca816a9da3291fde7455ae37b8 | 1360 | Pfam | PF09744 | JNK_SAPK-associated protein-1 | 21 | 175 | 1.8E-52 | T | 22-09-2020 | IPR019143 | JNK/Rab-associated protein-1, N-terminal |
| UnnamedSample_HQ_transcript/2543|m.1247 | UnnamedSample_HQ_transcript/2543 | Coverage 0.301 too low. | a2675aca816a9da3291fde7455ae37b8 | 1360 | Pfam | PF19056 | WD40 repeated domain | 999 | 1214 | 6.0E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/13608|m.4985 | UnnamedSample_HQ_transcript/13608 | Coverage 0.727 too low. | 88a052692d5b194ee91e9829cc248c75 | 1017 | Pfam | PF09380 | FERM C-terminal PH-like domain | 11 | 99 | 3.4E-24 | T | 22-09-2020 | IPR018980 | FERM, C-terminal PH-like domain |
| UnnamedSample_HQ_transcript/13608|m.4985 | UnnamedSample_HQ_transcript/13608 | Coverage 0.727 too low. | 88a052692d5b194ee91e9829cc248c75 | 1017 | Pfam | PF08736 | FERM adjacent (FA) | 107 | 147 | 7.2E-14 | T | 22-09-2020 | IPR014847 | FERM adjacent (FA) |
| UnnamedSample_HQ_transcript/13608|m.4985 | UnnamedSample_HQ_transcript/13608 | Coverage 0.727 too low. | 88a052692d5b194ee91e9829cc248c75 | 1017 | Pfam | PF05902 | 4.1 protein C-terminal domain (CTD) | 911 | 1011 | 6.8E-25 | T | 22-09-2020 | IPR008379 | Band 4.1, C-terminal |
| UnnamedSample_HQ_transcript/81809|m.20001 | UnnamedSample_HQ_transcript/81809 | Identity 0.940 too low. | a8e397b18887b87246e883f60b89755b | 356 | Pfam | PF01156 | Inosine-uridine preferring nucleoside hydrolase | 38 | 341 | 1.5E-58 | T | 22-09-2020 | IPR001910 | Inosine/uridine-preferring nucleoside hydrolase domain |
| UnnamedSample_HQ_transcript/77789|m.19338 | UnnamedSample_HQ_transcript/77789 | Coverage 0.989 too low. | a8e397b18887b87246e883f60b89755b | 356 | Pfam | PF01156 | Inosine-uridine preferring nucleoside hydrolase | 38 | 341 | 1.5E-58 | T | 22-09-2020 | IPR001910 | Inosine/uridine-preferring nucleoside hydrolase domain |
| UnnamedSample_HQ_transcript/63176|m.16669 | UnnamedSample_HQ_transcript/63176 | Coverage 0.966 too low. | 9912d10ce9c5bef28aa74cbde91edee7 | 534 | Pfam | PF00498 | FHA domain | 65 | 141 | 2.1E-16 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/69715|m.17879 | UnnamedSample_HQ_transcript/69715 | Unmapped. | 9d922bd9b7bc32bb261d90175ac815da | 575 | Pfam | PF13086 | AAA domain | 152 | 222 | 2.1E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/69715|m.17879 | UnnamedSample_HQ_transcript/69715 | Unmapped. | 9d922bd9b7bc32bb261d90175ac815da | 575 | Pfam | PF13087 | AAA domain | 335 | 506 | 2.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/10740|m.4059 | UnnamedSample_HQ_transcript/10740 | Coverage 0.944 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 1019 | 1142 | 3.0E-14 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/10740|m.4059 | UnnamedSample_HQ_transcript/10740 | Coverage 0.944 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 383 | 501 | 3.4E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/10740|m.4059 | UnnamedSample_HQ_transcript/10740 | Coverage 0.944 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 809 | 930 | 1.2E-18 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/10740|m.4059 | UnnamedSample_HQ_transcript/10740 | Coverage 0.944 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 198 | 318 | 1.8E-24 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/10740|m.4059 | UnnamedSample_HQ_transcript/10740 | Coverage 0.944 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF00754 | F5/8 type C domain | 34 | 159 | 6.0E-22 | T | 22-09-2020 | IPR000421 | Coagulation factor 5/8 C-terminal domain |
| UnnamedSample_HQ_transcript/10740|m.4059 | UnnamedSample_HQ_transcript/10740 | Coverage 0.944 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF00008 | EGF-like domain | 531 | 560 | 8.3E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/10740|m.4059 | UnnamedSample_HQ_transcript/10740 | Coverage 0.944 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF00008 | EGF-like domain | 953 | 976 | 1.4E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/3875|m.1763 | UnnamedSample_HQ_transcript/3875 | Coverage 0.956 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 1019 | 1142 | 3.0E-14 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3875|m.1763 | UnnamedSample_HQ_transcript/3875 | Coverage 0.956 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 383 | 501 | 3.4E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3875|m.1763 | UnnamedSample_HQ_transcript/3875 | Coverage 0.956 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 809 | 930 | 1.2E-18 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3875|m.1763 | UnnamedSample_HQ_transcript/3875 | Coverage 0.956 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF02210 | Laminin G domain | 198 | 318 | 1.8E-24 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3875|m.1763 | UnnamedSample_HQ_transcript/3875 | Coverage 0.956 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF00754 | F5/8 type C domain | 34 | 159 | 6.0E-22 | T | 22-09-2020 | IPR000421 | Coagulation factor 5/8 C-terminal domain |
| UnnamedSample_HQ_transcript/3875|m.1763 | UnnamedSample_HQ_transcript/3875 | Coverage 0.956 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF00008 | EGF-like domain | 531 | 560 | 8.3E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/3875|m.1763 | UnnamedSample_HQ_transcript/3875 | Coverage 0.956 too low. | c1aae253bfa00682d3769d33b12ebbcc | 1269 | Pfam | PF00008 | EGF-like domain | 953 | 976 | 1.4E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/102084|m.22876 | UnnamedSample_HQ_transcript/102084 | Coverage 0.929 too low. | 1557932ad9adcd626a22ee778e6d13e4 | 191 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 22 | 68 | 0.01 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/102084|m.22876 | UnnamedSample_HQ_transcript/102084 | Coverage 0.929 too low. | 1557932ad9adcd626a22ee778e6d13e4 | 191 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 84 | 129 | 0.0025 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/102084|m.22876 | UnnamedSample_HQ_transcript/102084 | Coverage 0.929 too low. | 1557932ad9adcd626a22ee778e6d13e4 | 191 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 145 | 190 | 0.0024 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/107341|m.23503 | UnnamedSample_HQ_transcript/107341 | Coverage 0.920 too low. | 1557932ad9adcd626a22ee778e6d13e4 | 191 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 22 | 68 | 0.01 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/107341|m.23503 | UnnamedSample_HQ_transcript/107341 | Coverage 0.920 too low. | 1557932ad9adcd626a22ee778e6d13e4 | 191 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 84 | 129 | 0.0025 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/107341|m.23503 | UnnamedSample_HQ_transcript/107341 | Coverage 0.920 too low. | 1557932ad9adcd626a22ee778e6d13e4 | 191 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 145 | 190 | 0.0024 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/5614|m.2396 | UnnamedSample_HQ_transcript/5614 | Coverage 0.771 too low. | 7c973db46d46ee2be3702c6bb2f8e57f | 483 | Pfam | PF00096 | Zinc finger, C2H2 type | 371 | 392 | 2.4E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/5614|m.2396 | UnnamedSample_HQ_transcript/5614 | Coverage 0.771 too low. | 7c973db46d46ee2be3702c6bb2f8e57f | 483 | Pfam | PF00096 | Zinc finger, C2H2 type | 428 | 449 | 4.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/5614|m.2396 | UnnamedSample_HQ_transcript/5614 | Coverage 0.771 too low. | 7c973db46d46ee2be3702c6bb2f8e57f | 483 | Pfam | PF00096 | Zinc finger, C2H2 type | 398 | 420 | 8.2E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/52645|m.14575 | UnnamedSample_HQ_transcript/52645 | Coverage 0.944 too low. | 6353e517f29ef87b5312b53bc02ab8c8 | 398 | Pfam | PF01433 | Peptidase family M1 domain | 3 | 192 | 4.9E-26 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/52645|m.14575 | UnnamedSample_HQ_transcript/52645 | Coverage 0.944 too low. | 6353e517f29ef87b5312b53bc02ab8c8 | 398 | Pfam | PF11838 | ERAP1-like C-terminal domain | 272 | 396 | 3.5E-27 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/27008|m.8719 | UnnamedSample_HQ_transcript/27008 | Coverage 0.896 too low. | 1b6b96d7b3bc288c2c57dd5a07559f36 | 826 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 600 | 1.1E-245 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/34498|m.10603 | UnnamedSample_HQ_transcript/34498 | Coverage 0.985 too low. | 1b6b96d7b3bc288c2c57dd5a07559f36 | 826 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 600 | 1.1E-245 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/67279|m.17455 | UnnamedSample_HQ_transcript/67279 | Identity 0.687 too low. | c667389513f318b45d1da830a5ff28d6 | 544 | Pfam | PF01431 | Peptidase family M13 | 336 | 539 | 3.5E-52 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/67279|m.17455 | UnnamedSample_HQ_transcript/67279 | Identity 0.687 too low. | c667389513f318b45d1da830a5ff28d6 | 544 | Pfam | PF05649 | Peptidase family M13 | 64 | 276 | 4.3E-24 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/19380|m.6696 | UnnamedSample_HQ_transcript/19380 | Coverage 0.987 too low. | dd14953197d726e272568adeaece6ad2 | 686 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 442 | 515 | 6.1E-12 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/49450|m.13897 | UnnamedSample_HQ_transcript/49450 | Identity 0.789 too low. | fa14fda51fd315cc68602e908be34ae0 | 679 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 101 | 136 | 6.4E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/49450|m.13897 | UnnamedSample_HQ_transcript/49450 | Identity 0.789 too low. | fa14fda51fd315cc68602e908be34ae0 | 679 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 145 | 180 | 1.0E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/49450|m.13897 | UnnamedSample_HQ_transcript/49450 | Identity 0.789 too low. | fa14fda51fd315cc68602e908be34ae0 | 679 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 185 | 219 | 2.8E-12 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/49450|m.13897 | UnnamedSample_HQ_transcript/49450 | Identity 0.789 too low. | fa14fda51fd315cc68602e908be34ae0 | 679 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 229 | 267 | 2.9E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/49450|m.13897 | UnnamedSample_HQ_transcript/49450 | Identity 0.789 too low. | fa14fda51fd315cc68602e908be34ae0 | 679 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 526 | 561 | 8.5E-5 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/49450|m.13897 | UnnamedSample_HQ_transcript/49450 | Identity 0.789 too low. | fa14fda51fd315cc68602e908be34ae0 | 679 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 483 | 518 | 1.8E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/71655|m.18241 | UnnamedSample_HQ_transcript/71655 | Coverage 0.847 too low. | 50852615ab4bee56fa2cc6e36b7e5b68 | 145 | Pfam | PF01553 | Acyltransferase | 1 | 74 | 2.1E-10 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/21994|m.7426 | UnnamedSample_HQ_transcript/21994 | Coverage 0.097 too low. | 3b4b9b1cb95255c199eea8da1ea3a483 | 868 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 51 | 138 | 7.7E-17 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/21994|m.7426 | UnnamedSample_HQ_transcript/21994 | Coverage 0.097 too low. | 3b4b9b1cb95255c199eea8da1ea3a483 | 868 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 197 | 266 | 1.2E-12 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/21994|m.7426 | UnnamedSample_HQ_transcript/21994 | Coverage 0.097 too low. | 3b4b9b1cb95255c199eea8da1ea3a483 | 868 | Pfam | PF15898 | cGMP-dependent protein kinase interacting domain | 768 | 868 | 7.8E-33 | T | 22-09-2020 | IPR031775 | cGMP-dependent protein kinase, interacting domain |
| UnnamedSample_HQ_transcript/32065|m.9967 | UnnamedSample_HQ_transcript/32065 | Coverage 0.882 too low. | 3b647606ec4614ae3c0b4949fc07568a | 822 | Pfam | PF08454 | RyR and IP3R Homology associated | 22 | 129 | 5.8E-30 | T | 22-09-2020 | IPR013662 | RyR/IP3R Homology associated domain |
| UnnamedSample_HQ_transcript/32065|m.9967 | UnnamedSample_HQ_transcript/32065 | Coverage 0.882 too low. | 3b647606ec4614ae3c0b4949fc07568a | 822 | Pfam | PF00520 | Ion transport protein | 345 | 674 | 6.0E-19 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/4305|m.1918 | UnnamedSample_HQ_transcript/4305 | Coverage 0.934 too low. | 3b647606ec4614ae3c0b4949fc07568a | 822 | Pfam | PF08454 | RyR and IP3R Homology associated | 22 | 129 | 5.8E-30 | T | 22-09-2020 | IPR013662 | RyR/IP3R Homology associated domain |
| UnnamedSample_HQ_transcript/4305|m.1918 | UnnamedSample_HQ_transcript/4305 | Coverage 0.934 too low. | 3b647606ec4614ae3c0b4949fc07568a | 822 | Pfam | PF00520 | Ion transport protein | 345 | 674 | 6.0E-19 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/56273|m.15294 | UnnamedSample_HQ_transcript/56273 | Coverage 0.536 too low. | 332893eff1e82e20fb1173d4d783a757 | 576 | Pfam | PF02872 | 5'-nucleotidase, C-terminal domain | 310 | 488 | 2.2E-39 | T | 22-09-2020 | IPR008334 | 5'-Nucleotidase, C-terminal |
| UnnamedSample_HQ_transcript/13914|m.5086 | UnnamedSample_HQ_transcript/13914 | Coverage 0.825 too low. | 933b83620eabac3321f49d8ccd2afbf0 | 308 | Pfam | PF13246 | Cation transport ATPase (P-type) | 43 | 89 | 2.5E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18264|m.6383 | UnnamedSample_HQ_transcript/18264 | Identity 0.612 too low. | 2c3771ca926b68d699e9577431ee69ed | 906 | Pfam | PF09758 | Uncharacterised conserved protein | 49 | 196 | 4.3E-60 | T | 22-09-2020 | IPR019155 | CLEC16A/TT9, N-terminal |
| UnnamedSample_HQ_transcript/3099|m.1479 | UnnamedSample_HQ_transcript/3099 | Coverage 0.838 too low. | b41854bb50cabf7e3d07a1ce0764458b | 1361 | Pfam | PF12698 | ABC-2 family transporter protein | 604 | 986 | 5.7E-34 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3099|m.1479 | UnnamedSample_HQ_transcript/3099 | Coverage 0.838 too low. | b41854bb50cabf7e3d07a1ce0764458b | 1361 | Pfam | PF12698 | ABC-2 family transporter protein | 1 | 179 | 4.8E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3099|m.1479 | UnnamedSample_HQ_transcript/3099 | Coverage 0.838 too low. | b41854bb50cabf7e3d07a1ce0764458b | 1361 | Pfam | PF00005 | ABC transporter | 1069 | 1212 | 4.0E-23 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/3099|m.1479 | UnnamedSample_HQ_transcript/3099 | Coverage 0.838 too low. | b41854bb50cabf7e3d07a1ce0764458b | 1361 | Pfam | PF00005 | ABC transporter | 239 | 382 | 2.7E-27 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/11925|m.4474 | UnnamedSample_HQ_transcript/11925 | Coverage 0.877 too low. | 9486fde2fd1b78d55019c0527e21f9a8 | 460 | Pfam | PF00053 | Laminin EGF domain | 154 | 197 | 0.054 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11925|m.4474 | UnnamedSample_HQ_transcript/11925 | Coverage 0.877 too low. | 9486fde2fd1b78d55019c0527e21f9a8 | 460 | Pfam | PF00053 | Laminin EGF domain | 282 | 327 | 0.0048 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/91458|m.21467 | UnnamedSample_HQ_transcript/91458 | Coverage 0.133 too low. | e71b00615fbd5d248910c79158feb71a | 283 | Pfam | PF01412 | Putative GTPase activating protein for Arf | 14 | 120 | 1.2E-32 | T | 22-09-2020 | IPR001164 | Arf GTPase activating protein |
| UnnamedSample_HQ_transcript/102198|m.22894 | UnnamedSample_HQ_transcript/102198 | Coverage 0.910 too low. | e71b00615fbd5d248910c79158feb71a | 283 | Pfam | PF01412 | Putative GTPase activating protein for Arf | 14 | 120 | 1.2E-32 | T | 22-09-2020 | IPR001164 | Arf GTPase activating protein |
| UnnamedSample_HQ_transcript/21507|m.7283 | UnnamedSample_HQ_transcript/21507 | Coverage 0.722 too low. | 2b7bf465fac6a466519bc59db882b8c7 | 865 | Pfam | PF00069 | Protein kinase domain | 542 | 838 | 3.0E-54 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/26563|m.8619 | UnnamedSample_HQ_transcript/26563 | Coverage 0.700 too low. | 2b7bf465fac6a466519bc59db882b8c7 | 865 | Pfam | PF00069 | Protein kinase domain | 542 | 838 | 3.0E-54 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/61105|m.16279 | UnnamedSample_HQ_transcript/61105 | Identity 0.929 too low. | e7e78974307e4c86b8d24f874bc981ac | 633 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 322 | 625 | 1.4E-95 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/24756|m.8156 | UnnamedSample_HQ_transcript/24756 | Coverage 0.265 too low. | c45bff308be51c5d991b5c66c704d97e | 884 | Pfam | PF04547 | Calcium-activated chloride channel | 283 | 853 | 1.6E-140 | T | 22-09-2020 | IPR007632 | Anoctamin |
| UnnamedSample_HQ_transcript/24756|m.8156 | UnnamedSample_HQ_transcript/24756 | Coverage 0.265 too low. | c45bff308be51c5d991b5c66c704d97e | 884 | Pfam | PF16178 | Dimerisation domain of Ca+-activated chloride-channel, anoctamin | 61 | 280 | 7.7E-59 | T | 22-09-2020 | IPR032394 | Anoctamin, dimerisation domain |
| UnnamedSample_HQ_transcript/31173|m.9755 | UnnamedSample_HQ_transcript/31173 | Coverage 0.574 too low. | 722cb52408bf257030b060e1e0349679 | 376 | Pfam | PF03281 | Mab-21 protein | 80 | 360 | 8.9E-77 | T | 22-09-2020 | IPR024810 | Mab-21 domain |
| UnnamedSample_HQ_transcript/26986|m.8714 | UnnamedSample_HQ_transcript/26986 | Coverage 0.596 too low. | 722cb52408bf257030b060e1e0349679 | 376 | Pfam | PF03281 | Mab-21 protein | 80 | 360 | 8.9E-77 | T | 22-09-2020 | IPR024810 | Mab-21 domain |
| UnnamedSample_HQ_transcript/33865|m.10425 | UnnamedSample_HQ_transcript/33865 | Coverage 0.653 too low. | 722cb52408bf257030b060e1e0349679 | 376 | Pfam | PF03281 | Mab-21 protein | 80 | 360 | 8.9E-77 | T | 22-09-2020 | IPR024810 | Mab-21 domain |
| UnnamedSample_HQ_transcript/113813|m.24269 | UnnamedSample_HQ_transcript/113813 | Coverage 0.860 too low. | 6875e71d9545f4a736c740364a9589cd | 198 | Pfam | PF00288 | GHMP kinases N terminal domain | 139 | 167 | 7.7E-7 | T | 22-09-2020 | IPR006204 | GHMP kinase N-terminal domain |
| UnnamedSample_HQ_transcript/113813|m.24269 | UnnamedSample_HQ_transcript/113813 | Coverage 0.860 too low. | 6875e71d9545f4a736c740364a9589cd | 198 | Pfam | PF10509 | Galactokinase galactose-binding signature | 25 | 72 | 6.0E-21 | T | 22-09-2020 | IPR019539 | Galactokinase, N-terminal domain |
| UnnamedSample_HQ_transcript/11198|m.4221 | UnnamedSample_HQ_transcript/11198 | Identity 0.613 too low. | 3c05f2a683558d93ea94bade32194215 | 790 | Pfam | PF01431 | Peptidase family M13 | 583 | 789 | 4.0E-71 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/11198|m.4221 | UnnamedSample_HQ_transcript/11198 | Identity 0.613 too low. | 3c05f2a683558d93ea94bade32194215 | 790 | Pfam | PF05649 | Peptidase family M13 | 134 | 522 | 7.4E-111 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/9553|m.3692 | UnnamedSample_HQ_transcript/9553 | Identity 0.915 too low. | 0d71290a63d01b65ae641128c3ac0288 | 455 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 190 | 298 | 3.8E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9553|m.3692 | UnnamedSample_HQ_transcript/9553 | Identity 0.915 too low. | 0d71290a63d01b65ae641128c3ac0288 | 455 | Pfam | PF00098 | Zinc knuckle | 393 | 409 | 0.0056 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/9553|m.3692 | UnnamedSample_HQ_transcript/9553 | Identity 0.915 too low. | 0d71290a63d01b65ae641128c3ac0288 | 455 | Pfam | PF00098 | Zinc knuckle | 426 | 442 | 1.4E-4 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/36035|m.10943 | UnnamedSample_HQ_transcript/36035 | Unmapped. | c121f56a182a46753d7f6095b95b7f83 | 840 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 444 | 811 | 8.2E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/80022|m.19721 | UnnamedSample_HQ_transcript/80022 | Coverage 0.988 too low. | 3c8b9b9a57fc8263db8cb88474f53a0f | 358 | Pfam | PF08551 | Eukaryotic integral membrane protein (DUF1751) | 55 | 157 | 2.3E-25 | T | 22-09-2020 | IPR013861 | TMEM115/Pdh1/Rbl19 |
| UnnamedSample_HQ_transcript/84478|m.20412 | UnnamedSample_HQ_transcript/84478 | Coverage 0.979 too low. | 3c8b9b9a57fc8263db8cb88474f53a0f | 358 | Pfam | PF08551 | Eukaryotic integral membrane protein (DUF1751) | 55 | 157 | 2.3E-25 | T | 22-09-2020 | IPR013861 | TMEM115/Pdh1/Rbl19 |
| UnnamedSample_HQ_transcript/73833|m.18618 | UnnamedSample_HQ_transcript/73833 | Identity 0.892 too low. | 3c8b9b9a57fc8263db8cb88474f53a0f | 358 | Pfam | PF08551 | Eukaryotic integral membrane protein (DUF1751) | 55 | 157 | 2.3E-25 | T | 22-09-2020 | IPR013861 | TMEM115/Pdh1/Rbl19 |
| UnnamedSample_HQ_transcript/20323|m.6955 | UnnamedSample_HQ_transcript/20323 | Coverage 0.577 too low. | 73b537432449db1248f8a34ad175858d | 378 | Pfam | PF10363 | Required for nuclear transport of RNA pol II C-terminus 1 | 125 | 228 | 7.0E-26 | T | 22-09-2020 | IPR019451 | RNA polymerase II assembly factor Rtp1, C-terminal |
| UnnamedSample_HQ_transcript/20323|m.6955 | UnnamedSample_HQ_transcript/20323 | Coverage 0.577 too low. | 73b537432449db1248f8a34ad175858d | 378 | Pfam | PF10304 | Required for nuclear transport of RNA pol II C-terminus 2 | 323 | 354 | 1.4E-4 | T | 22-09-2020 | IPR019414 | RNA polymerase II assembly factor Rtp1, C-terminal domain 2 |
| UnnamedSample_HQ_transcript/8107|m.3228 | UnnamedSample_HQ_transcript/8107 | Unmapped. | 0cec5640b96c119b19c4785fd6db1ceb | 1423 | Pfam | PF00270 | DEAD/DEAH box helicase | 770 | 929 | 1.4E-9 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/50808|m.14205 | UnnamedSample_HQ_transcript/50808 | Coverage 0.065 too low. | 3cea789db9e18ad4cf16bcf5560b175d | 530 | Pfam | PF13855 | Leucine rich repeat | 275 | 334 | 3.0E-15 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/50808|m.14205 | UnnamedSample_HQ_transcript/50808 | Coverage 0.065 too low. | 3cea789db9e18ad4cf16bcf5560b175d | 530 | Pfam | PF13855 | Leucine rich repeat | 477 | 530 | 2.2E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/50808|m.14205 | UnnamedSample_HQ_transcript/50808 | Coverage 0.065 too low. | 3cea789db9e18ad4cf16bcf5560b175d | 530 | Pfam | PF13855 | Leucine rich repeat | 53 | 112 | 5.3E-15 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/50808|m.14205 | UnnamedSample_HQ_transcript/50808 | Coverage 0.065 too low. | 3cea789db9e18ad4cf16bcf5560b175d | 530 | Pfam | PF01463 | Leucine rich repeat C-terminal domain | 183 | 206 | 0.0018 | T | 22-09-2020 | IPR000483 | Cysteine-rich flanking region, C-terminal |
| UnnamedSample_HQ_transcript/50808|m.14205 | UnnamedSample_HQ_transcript/50808 | Coverage 0.065 too low. | 3cea789db9e18ad4cf16bcf5560b175d | 530 | Pfam | PF01463 | Leucine rich repeat C-terminal domain | 405 | 428 | 0.11 | T | 22-09-2020 | IPR000483 | Cysteine-rich flanking region, C-terminal |
| UnnamedSample_HQ_transcript/50808|m.14205 | UnnamedSample_HQ_transcript/50808 | Coverage 0.065 too low. | 3cea789db9e18ad4cf16bcf5560b175d | 530 | Pfam | PF01462 | Leucine rich repeat N-terminal domain | 446 | 473 | 4.3E-9 | T | 22-09-2020 | IPR000372 | Leucine-rich repeat N-terminal domain |
| UnnamedSample_HQ_transcript/50808|m.14205 | UnnamedSample_HQ_transcript/50808 | Coverage 0.065 too low. | 3cea789db9e18ad4cf16bcf5560b175d | 530 | Pfam | PF01462 | Leucine rich repeat N-terminal domain | 222 | 249 | 8.1E-6 | T | 22-09-2020 | IPR000372 | Leucine-rich repeat N-terminal domain |
| UnnamedSample_HQ_transcript/35166|m.10747 | UnnamedSample_HQ_transcript/35166 | Coverage 0.230 too low. | 19181f06c63288cf2c5dbd08d74f2702 | 604 | Pfam | PF02210 | Laminin G domain | 456 | 583 | 1.6E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/35166|m.10747 | UnnamedSample_HQ_transcript/35166 | Coverage 0.230 too low. | 19181f06c63288cf2c5dbd08d74f2702 | 604 | Pfam | PF02210 | Laminin G domain | 279 | 405 | 3.8E-23 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/35166|m.10747 | UnnamedSample_HQ_transcript/35166 | Coverage 0.230 too low. | 19181f06c63288cf2c5dbd08d74f2702 | 604 | Pfam | PF02210 | Laminin G domain | 59 | 178 | 9.8E-13 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/2261|m.1160 | UnnamedSample_HQ_transcript/2261 | Unmapped. | 27a87d6464e4db380a49eca129b894d5 | 909 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 444 | 813 | 8.7E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/79848|m.19681 | UnnamedSample_HQ_transcript/79848 | Coverage 0.973 too low. | 9cd2b7c855a38616c9e7e8b92a5e7adb | 440 | Pfam | PF00135 | Carboxylesterase family | 1 | 430 | 9.4E-64 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/59180|m.15884 | UnnamedSample_HQ_transcript/59180 | Coverage 0.970 too low. | 1ab2fd5477d09c9d15e8ef142c6d7192 | 586 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 443 | 549 | 2.8E-14 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/59180|m.15884 | UnnamedSample_HQ_transcript/59180 | Coverage 0.970 too low. | 1ab2fd5477d09c9d15e8ef142c6d7192 | 586 | Pfam | PF00258 | Flavodoxin | 8 | 140 | 6.6E-31 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/59180|m.15884 | UnnamedSample_HQ_transcript/59180 | Coverage 0.970 too low. | 1ab2fd5477d09c9d15e8ef142c6d7192 | 586 | Pfam | PF00667 | FAD binding domain | 201 | 412 | 3.6E-33 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/4339|m.1931 | UnnamedSample_HQ_transcript/4339 | Coverage 0.139 too low. | 4ca95634c06417cd64bdcfcfee1e6060 | 1296 | Pfam | PF01582 | TIR domain | 1051 | 1195 | 3.2E-5 | T | 22-09-2020 | IPR000157 | Toll/interleukin-1 receptor homology (TIR) domain |
| UnnamedSample_HQ_transcript/4339|m.1931 | UnnamedSample_HQ_transcript/4339 | Coverage 0.139 too low. | 4ca95634c06417cd64bdcfcfee1e6060 | 1296 | Pfam | PF13855 | Leucine rich repeat | 357 | 416 | 9.3E-13 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/4339|m.1931 | UnnamedSample_HQ_transcript/4339 | Coverage 0.139 too low. | 4ca95634c06417cd64bdcfcfee1e6060 | 1296 | Pfam | PF13855 | Leucine rich repeat | 841 | 900 | 3.8E-11 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/4339|m.1931 | UnnamedSample_HQ_transcript/4339 | Coverage 0.139 too low. | 4ca95634c06417cd64bdcfcfee1e6060 | 1296 | Pfam | PF13855 | Leucine rich repeat | 142 | 186 | 1.0E-8 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/4339|m.1931 | UnnamedSample_HQ_transcript/4339 | Coverage 0.139 too low. | 4ca95634c06417cd64bdcfcfee1e6060 | 1296 | Pfam | PF13855 | Leucine rich repeat | 212 | 270 | 3.9E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/4339|m.1931 | UnnamedSample_HQ_transcript/4339 | Coverage 0.139 too low. | 4ca95634c06417cd64bdcfcfee1e6060 | 1296 | Pfam | PF13855 | Leucine rich repeat | 453 | 511 | 4.9E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 268 | 384 | 9.6E-40 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF08659 | KR domain | 1785 | 1963 | 2.6E-44 | T | 22-09-2020 | IPR013968 | Polyketide synthase, ketoreductase domain |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF00109 | Beta-ketoacyl synthase, N-terminal domain | 27 | 264 | 1.3E-68 | T | 22-09-2020 | IPR014030 | Beta-ketoacyl synthase, N-terminal |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 387 | 496 | 2.2E-36 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF14765 | Polyketide synthase dehydratase | 882 | 1078 | 6.6E-11 | T | 22-09-2020 | IPR020807 | Polyketide synthase, dehydratase domain |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF00698 | Acyl transferase domain | 516 | 830 | 9.4E-86 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF00107 | Zinc-binding dehydrogenase | 1577 | 1696 | 1.4E-18 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF00975 | Thioesterase domain | 2148 | 2396 | 2.4E-21 | T | 22-09-2020 | IPR001031 | Thioesterase |
| UnnamedSample_HQ_transcript/298|m.243 | UnnamedSample_HQ_transcript/298 | Coverage 0.933 too low. | b5e69fefe1f6bd4e827be6cee997b66b | 2404 | Pfam | PF00550 | Phosphopantetheine attachment site | 2025 | 2086 | 4.3E-7 | T | 22-09-2020 | IPR009081 | Phosphopantetheine binding ACP domain |
| UnnamedSample_HQ_transcript/9531|m.3685 | UnnamedSample_HQ_transcript/9531 | Coverage 0.793 too low. | 46a6d435b5a9d3ac80451515cf4d3210 | 1276 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 19 | 264 | 1.6E-32 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/13064|m.4833 | UnnamedSample_HQ_transcript/13064 | Coverage 0.748 too low. | ef81719f5cc169661a34b16f0b063f66 | 495 | Pfam | PF00102 | Protein-tyrosine phosphatase | 1 | 175 | 1.2E-42 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/13064|m.4833 | UnnamedSample_HQ_transcript/13064 | Coverage 0.748 too low. | ef81719f5cc169661a34b16f0b063f66 | 495 | Pfam | PF00102 | Protein-tyrosine phosphatase | 237 | 480 | 9.5E-54 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/101098|m.22761 | UnnamedSample_HQ_transcript/101098 | Coverage 0.167 too low. | 6e3f063506c844a2e9880c87c7e16a26 | 275 | Pfam | PF03098 | Animal haem peroxidase | 5 | 246 | 3.5E-84 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/100171|m.22668 | UnnamedSample_HQ_transcript/100171 | Coverage 0.232 too low. | 6e3f063506c844a2e9880c87c7e16a26 | 275 | Pfam | PF03098 | Animal haem peroxidase | 5 | 246 | 3.5E-84 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/24929|m.8203 | UnnamedSample_HQ_transcript/24929 | Coverage 0.951 too low. | aecb004a7a1cd579a9f7622a04b47981 | 570 | Pfam | PF04851 | Type III restriction enzyme, res subunit | 128 | 187 | 6.3E-6 | T | 22-09-2020 | IPR006935 | Helicase/UvrB, N-terminal |
| UnnamedSample_HQ_transcript/24929|m.8203 | UnnamedSample_HQ_transcript/24929 | Coverage 0.951 too low. | aecb004a7a1cd579a9f7622a04b47981 | 570 | Pfam | PF18141 | Domain of unknown function (DUF5599) | 1 | 58 | 2.1E-15 | T | 22-09-2020 | IPR040812 | Domain of unknown function DUF5599 |
| UnnamedSample_HQ_transcript/24929|m.8203 | UnnamedSample_HQ_transcript/24929 | Coverage 0.951 too low. | aecb004a7a1cd579a9f7622a04b47981 | 570 | Pfam | PF13087 | AAA domain | 326 | 521 | 3.9E-58 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/24929|m.8203 | UnnamedSample_HQ_transcript/24929 | Coverage 0.951 too low. | aecb004a7a1cd579a9f7622a04b47981 | 570 | Pfam | PF13086 | AAA domain | 215 | 315 | 1.1E-26 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/13688|m.5011 | UnnamedSample_HQ_transcript/13688 | Coverage 0.181 too low. | e31be2aacbb3d9d3c0769bbd14a4eb36 | 752 | Pfam | PF13906 | C-terminus of AA_permease | 617 | 667 | 7.4E-18 | T | 22-09-2020 | IPR029485 | Cationic amino acid transporter, C-terminal |
| UnnamedSample_HQ_transcript/13688|m.5011 | UnnamedSample_HQ_transcript/13688 | Coverage 0.181 too low. | e31be2aacbb3d9d3c0769bbd14a4eb36 | 752 | Pfam | PF13520 | Amino acid permease | 21 | 393 | 3.6E-42 | T | 22-09-2020 | IPR002293 | Amino acid/polyamine transporter I |
| UnnamedSample_HQ_transcript/92568|m.21607 | UnnamedSample_HQ_transcript/92568 | Coverage 0.738 too low. | f24de699417248c5bdaf194ac5324c8e | 117 | Pfam | PF02121 | Phosphatidylinositol transfer protein | 1 | 114 | 2.3E-51 | T | 22-09-2020 | IPR001666 | Phosphatidylinositol transfer protein |
| UnnamedSample_HQ_transcript/10944|m.4131 | UnnamedSample_HQ_transcript/10944 | Identity 0.931 too low. | 3470d1eea5a515f30a2a08c3ec56a8eb | 209 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 52 | 131 | 3.8E-5 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/44294|m.12771 | UnnamedSample_HQ_transcript/44294 | Coverage 0.140 too low. | 7c6eca69d93fdedecea0d3e3feb24625 | 558 | Pfam | PF00644 | Poly(ADP-ribose) polymerase catalytic domain | 440 | 558 | 7.8E-45 | T | 22-09-2020 | IPR012317 | Poly(ADP-ribose) polymerase, catalytic domain |
| UnnamedSample_HQ_transcript/44294|m.12771 | UnnamedSample_HQ_transcript/44294 | Coverage 0.140 too low. | 7c6eca69d93fdedecea0d3e3feb24625 | 558 | Pfam | PF08063 | PADR1 (NUC008) domain | 52 | 104 | 3.0E-18 | T | 22-09-2020 | IPR012982 | PADR1 domain |
| UnnamedSample_HQ_transcript/44294|m.12771 | UnnamedSample_HQ_transcript/44294 | Coverage 0.140 too low. | 7c6eca69d93fdedecea0d3e3feb24625 | 558 | Pfam | PF05406 | WGR domain | 188 | 267 | 1.6E-20 | T | 22-09-2020 | IPR008893 | WGR domain |
| UnnamedSample_HQ_transcript/44294|m.12771 | UnnamedSample_HQ_transcript/44294 | Coverage 0.140 too low. | 7c6eca69d93fdedecea0d3e3feb24625 | 558 | Pfam | PF02877 | Poly(ADP-ribose) polymerase, regulatory domain | 289 | 425 | 9.7E-47 | T | 22-09-2020 | IPR004102 | Poly(ADP-ribose) polymerase, regulatory domain |
| UnnamedSample_HQ_transcript/9263|m.3589 | UnnamedSample_HQ_transcript/9263 | Identity 0.685 too low. | 518366b3e21a303effb8b3896b7e4cb1 | 309 | Pfam | PF12057 | BCL2-associated athanogene 6 | 36 | 124 | 2.6E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/20769|m.7082 | UnnamedSample_HQ_transcript/20769 | Coverage 0.553 too low. | 6976f145a89e2e17ea32bad55603359c | 904 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 820 | 834 | 3.1 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/20769|m.7082 | UnnamedSample_HQ_transcript/20769 | Coverage 0.553 too low. | 6976f145a89e2e17ea32bad55603359c | 904 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 575 | 588 | 1.6 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/20769|m.7082 | UnnamedSample_HQ_transcript/20769 | Coverage 0.553 too low. | 6976f145a89e2e17ea32bad55603359c | 904 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 781 | 793 | 15 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/20769|m.7082 | UnnamedSample_HQ_transcript/20769 | Coverage 0.553 too low. | 6976f145a89e2e17ea32bad55603359c | 904 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 248 | 258 | 31 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/20769|m.7082 | UnnamedSample_HQ_transcript/20769 | Coverage 0.553 too low. | 6976f145a89e2e17ea32bad55603359c | 904 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 693 | 711 | 9.5 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
